Sai Life Sciences Ltd

{"actualRevenue":6021390000,"estimateRevenue":6567000000,"revenueSurprise":-545610000,"revenueSurprisePercent":-8.308359981726817,"actualEPS":4.86,"estimateEPS":5.049,"surprise":-0.1890000000000001,"surprisePercent":-3.743315508021392}

{"actualRevenue":5564640000,"estimateRevenue":5322000000,"revenueSurprise":242640000,"revenueSurprisePercent":4.559188275084555,"actualEPS":5.1,"estimateEPS":3.774,"surprise":1.325999999999999,"surprisePercent":35.13513513513511}

{"actualRevenue":5374700000,"estimateRevenue":5069000000,"revenueSurprise":305700000,"revenueSurprisePercent":6.030775300848293,"actualEPS":3.93,"estimateEPS":2.856,"surprise":1.074,"surprisePercent":37.60504201680673}

{"description":"Sai Life Sciences reported Q4 2026 earnings with strong revenue and profit growth, alongside plans for sizeable capex to expand operations despite execution challenges.","url":"https://finance.yahoo.com/markets/stocks/articles/sai-life-sciences-ltd-nse-010316537.html","sentiment":"Positive","domain":"Yahoo Finance"}

{"description":"Sai Life Sciences shared multiple investor updates, including Q4/FY26 audited results on 31 March 2026, an earnings call transcript, investor presentation, analyst meet outcomes, ESOP allotments and tax/GST order disclosures.","url":"https://money.rediff.com/companies/news/All/Sai-Life-Sciences-Ltd/12541818","sentiment":"Neutral","domain":"Rediff Money"}

{"description":"Sai Life Sciences shares surged over 8% following an impressive 86% year-on-year increase in Q3FY26 net profit, attributed to robust revenue growth. This performance highlights the company's strong financial health and market position.","url":"https://www.business-standard.com/markets/news/sai-life-sciences-shares-jump-8-as-q3-profit-surges-86-yoy-126020600687_1.html","sentiment":"Positive","domain":"Business Standard"}

{"description":"Sai Life Sciences shares rose 5% as 20.95 million shares were traded on BSE, indicating significant market activity. Check for block deal details.","url":"https://www.business-standard.com/markets/news/sai-life-sciences-up-5-amid-heavy-volume-20-9-mn-shares-change-hands-125062000304_1.html","sentiment":"Positive","domain":"Business Standard"}

{"description":"TPG Asia plans to sell shares of Sai Life Sciences valued at Rs 850 crore through a block deal, as reported by CNBC-Awaaz.","url":"https://www.moneycontrol.com/news/business/markets/tpg-asia-likely-to-sell-sai-life-sciences-shares-worth-rs-850-crore-via-block-deal-cnbc-awaaz-13147220.html","sentiment":"Negative","domain":"Moneycontrol"}